跳至主要内容
临床试验/EUCTR2005-003516-29-DE
EUCTR2005-003516-29-DE
进行中(未招募)
不适用

Prospective, randomized, double-blinded clinical trial on remifentanil for analgesia and sedation of ventilated neonates and infants - RAPIP-Pilotstudie

niversität zu Köln0 个研究点2006年10月20日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Meanwhile it is widely accepted, that ventilated newborns and infants should receive analgesia and sedation for ethical and medical reasons. In this context fentanyl belongs to the mosten often used opioids, with the important disadvantage of prolonged depression of respiratory drive after discontinuation of the infusion.In this clinical trial ventilated term newborns and infants (<60 days) receive either remifentanil or fentanyl for analgesia and sedation.
发起方
niversität zu Köln
状态
进行中(未招募)
最后更新
12年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2006年10月20日
结束日期
待定
最后更新
12年前
研究类型
Interventional clinical trial of medicinal product
性别
All

研究者

发起方
niversität zu Köln

入排标准

入选标准

  • Ventilated term newborns and infants \< 60 days.
  • Expected time of artificial ventilation between 12 and 96 hours.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) no
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

排除标准

  • Various conditions of neuromuscular impairment e.g. severe peripartal asphyxia, cerebral infarct, congenital muscular diseases or metabolic defects showing distinct neuromuscular symptoms.
  • Drug abuse of the mother (exclusion criterion for newborns).
  • Known hypersensitivity to Ultiva®, Fentanyl\-Janssen® or fentanyle equivalents.
  • Missing informed consent of the parents.
  • Participation in another clinical trial during or within the last 4 weeks before start of this trial.

结局指标

主要结局

未指定

相似试验